The choppy waters of this year’s market have forced a significant slowdown in digital health investment, but buyers and builders alike are seizing the moment to consider mergers and acquisitions (M&A) as strategic opportunities. We’ve seen big ticket M&A deals1 dominate 2022’s healthcare news cycle, while valuation declines, customer overwhelm, and an unfriendly IPO market continue to raise expectations for growing digital health M&A activity—even compelling one company to issue a statement swatting down acquisition rumors.
